PhD Career Stories: Therapeutic Start-Up
Sareina Wu, PhD
FOUNDER/CHIEF EXECUTIVE OFFICER
- Dr. Sareina Wu is a pioneer in the field of virus-free gene therapy and has been internationally recognized for her work in the field of piggyBac transposons. In striving to reach the pinnacle in the field of gene therapy, Dr. Wu founded the innovation-driven therapeutics company GenomeFrontier in 2018. Dr. Wu applied her research findings toward the development of four crucial proprietary virus-free gene and cell engineering platforms (GTailor™, Quantum Nufect™, Quantum pBac™, and iCellar™), which GenomeFrontier has leveraged to successfully create a robust cell engineering system called Quantum Engine™. This system has the potential to cure a wide range of diseases, including cancer. Dr. Wu is currently using this system to demonstrate its therapeutic effectiveness in cancer treatment. She leads the company research team in the development of several pipelines of chimeric antigen receptor T (CAR T) and T cell receptor T (TCR T) genetic reprograming cell products for cancer treatment.
- Prior to founding GenomeFrontier, Dr. Wu founded Celgenomics, LLC in 2007 in Georgia, USA where she focused on the development of human gene therapy for the treatment of neurodegenerative diseases. She also served as Assistant Research Professor at Chang Gung University and was a Faculty member at the Medical College of Georgia. Dr. Wu received her doctoral degree from Vanderbilt University under the mentorship of Drs. Brigid Hogan and Peter Kolodziej, and carried out her postdoctoral training at UC Santa Cruz.